Research from Hebrew University points to some promising channel blockers that could be studied as antiviral treatments for SARS-CoV-2.
By Abigail Klein Leichman | posted 7/20/2021
Research from Hebrew University points to some promising channel blockers that could be studied as antiviral treatments for SARS-CoV-2.
By Abigail Klein Leichman | posted 7/20/2021